Prime Medicine, Inc. (PRME)
NASDAQ·Healthcare·Biotechnology
$2.79
-1.24%
Mkt Cap $552.69M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
Implied Upside
+519.4%
Consensus $17.25 vs current $2.79
NASDAQ·Healthcare·Biotechnology
$2.79
-1.24%
Mkt Cap $552.69M
No recent rating data.
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
+519.4%
Consensus $17.25 vs current $2.79